Premixed formulations of insulin lispro [13]

Diabetes Care

Volumn 22, Issue 5, 1999, Pages 865-866

  Rave, Klaus ^a   Heinemann, Lutz ^a   Puhl, Lothar ^a   Gudat, Uwe ^b   Woodworth, James R ^c   Weyer, Christian ^a   Heise, Tim ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b LILLY DEUTSCHLAND GMBH   (Germany)

^c ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN LISPRO;

ADULT; CLINICAL ARTICLE; DRUG ACTIVITY; DRUG FORMULATION; DRUG STABILITY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE INFUSION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN SENSITIVITY; INSULIN TREATMENT; LETTER; MALE; METABOLIC ACTIVATION; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0032954656     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.22.5.865     Document Type: Letter

References (3)

1. DeFelippis MR, Bakaysa DL, Bell MA, Heady MA, Li S, Pye S, Youngman KM, Radziuk J, Frank BH: Preparation and characterization of a cocrystalline suspension of [LysB28,ProB29]-human insulin analogue. J Pharm Sci 87:170-176, 1998
2. Heise T, Weyer C, Servas A, Heinrichs S, Osinga J, Roach P, Woodworth J, Gudat U, Heinemann L: Time-action profiles of novel premixed preparations of insulin lispro and NPL insulin. Diabetes Care 21:800-803, 1998
3. Radziuk J, Bradley BJ, Welsh L, DeFelippis MR, Roach P: Profiles of biological activity after subcutaneous administration of mixtures of (Lys{B28}-Pro{B29} human) insulin (Lispro) in soluble and neutral protamine formulations (Abstract). Diabetes 45:218A, 1996